Alnylam Pharmace. buy HC Wainwright
Summary
This prediction is currently active. The BUY prediction by HC_Wainwright for Alnylam Pharmace. is nearly unchanged. This prediction currently runs until 20.08.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w |
---|---|
Alnylam Pharmace. | -0.48% |
iShares Core DAX® | 3.126% |
iShares Nasdaq 100 | 3.003% |
iShares Nikkei 225® | 4.991% |
iShares S&P 500 | 1.852% |
Comments by HC_Wainwright for this prediction
In the thread Alnylam Pharmace. diskutieren
Stopped prediction by HC_Wainwright for Alnylam Pharmace.
Alnylam Pharmace.
07.08.23
07.08.24
08.08.24
Alnylam Pharmace.
03.03.23
03.03.24
04.03.24